Sign inJoin waitlistJoin the waitlist

Geoffrey R Oxnard

Associate Professor of Medicine · Harvard Medical School

Credentials: · · ·

History

Harvard Medical School
Present

Research

Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M
Nature Medicine · 2015 · Last of 16 authors · 1,323 citations
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
Annals of Oncology · 2020 · 1,137 citations
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
Review · Journal of Clinical Oncology · 2018 · 748 citations

Pasi Jänne
48 papers
Lynette Sholl
28 papers
Jeffrey Ross
22 papers
MK
Mark Kris
13 papers
LS
Lawrence Schwartz
12 papers
Lecia Sequist
12 papers
ML
Marc Ladanyi
12 papers
AS
Adrian Sacher
11 papers
BD
Brennan Decker
11 papers · 1 as a resident
MA
Mark Awad
10 papers
RA
Ryan Alden
10 papers
VM
Vincent Miller
10 papers

Grants

Study of Plasma Next Generation Sequencing for Remote Assessment, Characterization, Evaluation of Patients with ALK Drug Resistance (SPACEWALK)
National Cancer Institute · R21
Contact PI · $230.3K · Dana-Farber Cancer Inst
2018–2020

Clinical trials

Study of Plasma NGS for Assessment, Characterization, Evaluation of Patients With ALK Resistance
Principal investigator · Completed
Addario Lung Cancer Medical Institute
2019–2023
Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer
Principal investigator · Terminated · Phase 2
Dana-Farber Cancer Institute
2016–2019
Sunitinib in Never-Smokers With Lung Adenocarcinoma
Principal investigator · Completed · Phase 2
Dana-Farber Cancer Institute
2013–2018